The Hidden Hepatic Hazard: Why Women Face Higher Risks of Drug-Induced Liver Injury
Women face a significantly higher incidence and severity of idiosyncratic drug-induced liver injury due to metabolic enzyme variability and historical trial exclusion. This article examines the physiological mechanisms, diagnostic delays, and necessary regulatory corrections.